Dr. Lal Pathlabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2024 inter alia to consider and approve Un-audited (Standalone & Consolidated) Financial Results of the Company for the Quarter ended June 30 2024 and to consider recommending Interim Dividend if any on the Equity Shares of the Company for the Financial Year 2024-25.